Test Price
2,800 AED✅ Home Collection Available
MYH7 Gene Cardiomyopathy (Dilated Type 1S) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MYH7 لاعتلال عضلة القلب التوسعي (النمط 1S) بتقنية التسلسل الجيني الشامل (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026
Executive Clinical Summary & Guarantee
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- ✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM–11 PM).
- ✓ Clinical Guidance: Telephonic Post‑Test Clinical Interpretation by DHA‑licensed specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي
ضمان الدقة: حساسية تشخيصية 99.9% عبر معالجة معتمدة من ISO 9001:2015. خدمة سحب منزلي عالية الجودة بتبريد معتمد وجمع عينات عبر ممرضين متنقلين. استشارة هاتفية بعد النتيجة مع أطباء مرخصين من هيئة الصحة بدبي. التحقق المباشر من التأمين الصحي عبر واتساب +971545488731.
Overview
This Next‑Generation Sequencing (NGS) test analyses the entire coding region of the MYH7 gene to detect pathogenic variants causing dilated cardiomyopathy type 1S, enabling definitive diagnosis, family risk stratification, and personalised cardiac management. يستخدم هذا الاختبار تقنية التسلسل الجيني الشامل لتحليل جين MYH7 وتحديد الطفرات المسببة لاعتلال عضلة القلب التوسعي من النمط 1S.
| Feature | Our MYH7 NGS Test | Closest Alternative (Sanger Sequencing Single‑Exon) |
|---|---|---|
| Precision | Full gene sequencing with copy number variant detection (>99% coverage) | Limited to pre‑selected exons; miss deep intronic mutations |
| Methodology | Illumina NGS platform, clinically validated | Sanger chain‑termination method |
| Turnaround Time | 3–4 Weeks | 6–10 Weeks (stepwise exon testing) |
Physician Insight & Safety Protocol
“A MYH7 variant alone does not make a diagnosis; clinical correlation with echocardiography, family history, and symptom assessment is essential. This test provides powerful data, but only your treating cardiologist can interpret it within your full clinical picture. As a DHA‑licensed cardiologist, I strongly recommend pre‑ and post‑test genetic counselling.” – Dr. PRABHAKAR REDDY, DHA Licence: 61713011.
⚠️ Critical Medication Warning
Do not discontinue prescribed medication (e.g., beta‑blockers, ACE inhibitors) without consulting your doctor. This test does not replace emergency cardiac evaluation.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do Not Proceed with Home Collection)
- Acute chest pain or shortness of breath at rest
- Syncope (fainting) within the past 24 hours
- Unstable vital signs (systolic BP <90 mmHg, heart rate >120 bpm)
- Known active COVID‑19 infection
- Inability to provide informed consent (cognitive impairment without legal guardian)
🚨 Emergency Red Flags – Seek Immediate Medical Attention
- Sudden severe chest pressure or pain
- Loss of consciousness
- Rapid, irregular heartbeat with dizziness
- Difficulty breathing that worsens when lying flat
Patient FAQ & Clinical Guidance
Q: What exactly does this MYH7 NGS test detect and how long does it take?
Snippet: This test analyses all coding exons and flanking regions of the MYH7 gene by Next Generation Sequencing, returning a comprehensive result in 3 to 4 weeks.
The assay identifies single nucleotide variants, small insertions/deletions, and copy number changes linked to dilated cardiomyopathy type 1S. The 3‑4 week turnaround includes bioinformatic analysis and clinical interpretation by a board‑certified molecular geneticist.
Q: Is genetic counselling required before giving a blood sample?
Snippet: A pre‑ genetic counselling session is strongly recommended to draw a family pedigree and explain potential outcomes, ensuring informed consent.
Our service includes a mandatory counselling session (via teleconsultation) where a genetic counsellor assesses your family history, discusses possible results (pathogenic, VUS, negative), and documents informed consent as per UAE CDS Law 2026 for genetic testing.
س: هل يمكن للأطفال إجراء هذا الاختبار؟
الملخص: يسمح بإجراء الاختبار للأطفال القصر فقط بوجود موافقة الوالدين القانونية وبعد استشارة طبيب أطفال مختص.
بموجب قانون الفحص الجيني الإماراتي لعام 2026، يتطلب اختبار القاصرين موافقة الوالدين وتقييم الفائدة السريرية المباشرة من قبل أخصائي أمراض قلب الأطفال.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians